William Blair & Company
SVNT

William Blair & Company’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

William Blair & Company’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-170,000
Closed -$95K – 2120
2013
Q2 		$95K Buy
+170,000
New +$118K ﹤0.01% 1889

Other funds holding SVNT

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair & Company's SVNT Position: Q3 2013 in Review

William Blair & Company sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q3 2013, closing a stake of 170,000 shares — an estimated $95K sold.

William Blair & Company first reported a position in SVNT in Q2 2013 and held it in 1 quarter. The position peaked at $95K in Q2 2013. 41 funds tracked by Wall St. Rank hold SVNT as of Q3 2013.

  • William Blair & Company reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • William Blair & Company sold 170,000 SAVIENT PHARMACEUTICALS INC shares in Q3 2013, an estimated $95K.
  • William Blair & Company first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • William Blair & Company's SAVIENT PHARMACEUTICALS INC position peaked at $95K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q3 2013.

Based on William Blair & Company's 13F filing for Q3 2013, filed 12 Nov 2013.